Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    19158356 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety/Effectiveness Study of Cysteamine Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis
Condition: Cystinosis
Intervention: Drug: RP103 Q12H
2 Not yet recruiting Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Condition: Focal Segmental Glomerulosclerosis 1
Intervention: Device: Liposorber® LA-15 System
3 Active, not recruiting Prediction of Delayed Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL
Condition: ALL
Intervention: Drug: IOHEXOL
4 Active, not recruiting Open-Label Safety & Superior Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cystinosis
Condition: Cystinosis
Interventions: Drug: RP103 Q12H;   Drug: Cystagon Q6H
5 Recruiting Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.
Condition: Autosomal Dominant Hypophosphatemic Rickets
Intervention: Dietary Supplement: Iron
6 Recruiting Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)
Condition: Chronic Kidney Disease
Intervention:
7 Completed Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Condition: Hypertension
Intervention: Drug: Lisinopril

Indicates status has not been verified in more than two years